| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |